There is a concurrent, ongoing federal criminal investigation, led by the Antitrust Division of the United States Department of Justice (DOJ) and a 47-state investigation, led by the Attorney General of Connecticut. To date, these investigations have resulted in price-fixing guilty pleas from two senior executives at defendant Heritage Pharmaceuticals, Inc. relating to the sale of generic glyburide and doxycycline hyclate.
The cases have been consolidated before Judge Cynthia Rufe in the Eastern District of Pennsylvania under the caption In re: Generic Pharmaceuticals Pricing Antitrust Litigation, MDL 2724 (E.D. PA). On November 28, 2016, the court appointed Hausfeld to the Plaintiffs’ Steering Committee, which has responsibility for litigating the case.